Session Details

[P3-04]Poster Session 3-04 Cancer Genetics 3

Sat. Oct 12, 2024 1:25 PM - 2:25 PM JST
Sat. Oct 12, 2024 4:25 AM - 5:25 AM UTC
Poster Room

[P3-04-1]Clinical evaluation of advanced and recurrent breast cancer patients undergoing comprehensive genomic profiling test

Jun Yamamura, Maika Yoshioka, Yukiko Miyamura, Shunji Kamigaki, Riyo Yoshii (Sakai City Medical Center)

[P3-04-2]Cascade genetic testing for HBOC relatives: verified from 117 families' genetic counseling

Keika Kaneko1, Akito Dobashi2, Hiromi Arakawa1, Eri Habano1, Yuko Minoura1, Asami Kuga1, Kota Ishioka1, Naomi Hayashi1, Takahiro Kogawa1, Arisa Ueki1 (1.The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, 2.The Cancer Institute, Japanese Foundation for Cancer Research)

[P3-04-3]Two cases in which BRACAnalysis results changed from VUS to Mutation identified with Special Interpretation

Yui Niwa1, Emiko Niiro1,2, Hajime Yasuhara1,3, Chiharu Yoshimoto1,2, Toshiyuki Sado1,2 (1.Department of Medical Genetics, Nara Prefecture General Medical Center, Nara, Japan, 2.Department of Obstetrics and gynecology, Nara Prefecture General Medical Center, 3.Neonatal Intensive Care Unit, Nara Prefecture General Medical Center)

[P3-04-4]Outcome of Risk Reducing Laparoscopic Salpingo-oophorectomy for Hereditary Breast and Ovarian Cancer

Yayoi Higuchi1, Chiaki Izumiya1, Takuya Matsuura1, Yusuke Ujihara1, Takashi Ushiwaka1, Mari Tashiro2, Toru Kubo2,3, Nagamasa Maeda1 (1.Department of Obstetrics and Gynecology, Kochi Medical School Hospital, 2.Department of Clinical Genetics, Kochi Medical School Hospital, 3.Department of Cardiology and Geriatrics, Kochi Medical School Hospital)

[P3-04-5]Six cases of HBOC off-tumor with PGPV of BRCA identified through comprehensive cancer genome profiling testing

Mihoko Doi1,5, Kanako Iwami1, Hanae Satano1, Midori Noma1,2, Yuko Shiroyama1,3, Shunsuke Shinmei4, Mitsuru Kajiwara4, Takehiko Morioka5, Katsunori Shinozaki5, Nobuhisa Ishikawa6, Takashi Nishisaka1,7 (1.Department of Genomic Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan, 2.Department of Breast Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan, 3.Department of Obstetrics and Gynecology, Hiroshima Prefectural Hospital, Hiroshima, Japan, 4.Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan, 5.Division of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Japan, 6.Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan, 7.Department of Pathology and Laboratory Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan)

[P3-04-6]Challenges Insighted from Risk-Reducing salpingo-oophorectomy (RRSO) in Women with HBOC

Yumi Matsuyama1,2,5, Hisanori Matsumoto1,4, Kaori Akazawa3, Eri Ogura4, Yusuke Fujikami4, Kana Akagi4, Kenji Ban4, Takako Tobiume4, Keiji Tatsumi4, Yonehiro Kanemura1,2, Hiroyuki Yasojima1,3 (1.Clinical Genetics Center, NHO Osaka National Hospital, Osaka, Japan, 2.Division of Molecular Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan, 3.Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan, 4.Department of Obstetrics and Gynecology, NHO Osaka National Hospital, Osaka, Japan, 5.Clinical Genetics Center, Gifu University Hospital)

[P3-04-7]Analyzing Japanese familial breast cancer through whole exome sequencing analysis

Yosuke Matsushita1, Ili Syazwana Abdullah1, Yasuko Takahashi2, Masato Komatsu2, Kazuma Kiyotani2, Yasuo Miyoshi3, Junko Honda4, Keiichi Kontani5, Shozo Ohsumi6, Mitsunori Sasa7, Toyomasa Katagiri1,2 (1.Laboratory of Biofunctional molecular Medicine, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan, 2.Div. Genome Med., Inst. for Genome Res., Tokushima University, 3.Department of Breast and Endocrine Surg., Hyogo College of Med., 4.Department Surg. Natl. Hospital Org. Kochi Natl. Hospital, 5.Department Breast and Endocrine Surg., Kagawa University Hospital, 6.Department Breast Surg. Natl. Hospital Org. Shikoku Cancer Ctr., 7.Department Surg., Tokushima Breast Care Clinic)

[P3-04-8]An 18-year-old patient with gender incongruence and HBOC who underwent RRSO and BRRM simultaneously with SRS

Chiaki Kashino1, Chikako Ogawa1, Akiko Ohira1, Junko Haraga1, Takashi Mitsui1, Eriko Eto1, Yuko Takahashi2, Tsuguo Iwatani2, Tadahiko Shien2, Risa Osumi3, Fumino Kato3, Mashu Futagawa3, Fukano Chika3, Hideki Yamamoto3, Akira Hirasawa3, Mikiya Nakatsuka4, Hisashi Masuyama1 (1.Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 2.Department of Breast and Endocrine Surgery, Okayama University Hospital, 3.Department of Clinical Genetics, Okayama University Hospital, 4.Okayama University Graduate School of Health Sciences.)

[P3-04-9]Pathological Evaluation Methods in Contralateral Risk-reduction Mastectomy in Patients with BRCA Positive Breast Cancer

Ai Motoyoshi1,2, Maho Ogiwara2, Yuika Ono2, Minami Ozawa2, Yuki Suzuki2, Yodo Sugishita2, Kohei Yoshioka2, Sachiko Ohori2, Osuke Migita2, Koichiro Tsugawa1,2 (1.Department of Breast & Endocrine Surgery, St. Marianna University School of Medicine, Kanagawa, Japan, 2.Department of Genetic Medicine, St. Marianna University School of Medicine, Kanagawa, Japan)

[P3-04-10]Multidisciplinary team care for patient and relative with RAD51 germline pathogenic variant

Riyo Yoshii, Naoko Kawata, Takuhei Yokoyama, Jun Yamamura (Sakai City Medical Center, Osaka, Japan)

[P3-04-11]Clinical Characteristics of ATM Germline Pathogenic Variants: Insights from 11 Families

Asami Kuga1, Keika Kaneko1, Hiromi Arakawa1, Eri Habano1, Yuko Minoura1, Kota Ishioka1, Naomi Hayashi1, Akito Dobashi1,2, Takahiro Kogawa1, Arisa Ueki1 (1.The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 2.The Cancer Institute, Japanese Foundation for Cancer Research)

[P3-04-12]Matched-pair analysis of the blood and MSI-H tumor tissues from patients counseled due to suspicion of Lynch syndrome

Miho Ando1, Sayuri Hiraoka1, Keiichi Iwaya1, Haruhiko Sugimura2, Tadashi Nomizu3, Miki Okamura4, Shozo Osumi4, Moriya Iwaizumi5, Takahiro Yoshioka6, Aki Ishikawa7, Akihiro Sakurai7, Takeshi Kuwata8, Sekine Shigeki9, Manami Matsukawa10, Noriko Tanabe10, Makoto Hirata10, Teruhiko Yoshida10, Kokichi Sugano1,10 (1.Department Genetic Medicine, Kyoundo Hospital, Sasaki Foundation, Tokyo, Japan, 2.Sasaki Institute, Sasaki Foundation, 3.Department of Surgery, Breast Cancer Center, Familial Tumor Clinic, Hoshi General Hospital, 4.Department of Hereditary Tumors, National Hospital Organization, Shikoku Cancer Center, 5.Clinical and Molecular Genetics Center, Hamamatsu University School of Medicine, 6.Department of Surgery, Kochi Health Sciences Center, 7.Department of Medical Genetics, Sapporo Medical University School of Medicine, 8.Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, 9.Department of Pathology, Keio University School of Medicine, 10.Department of Genetic Medicine and Services, National Cancer Center Hosp)

[P3-04-13]Genomic profiling of multiple tissues in two patients with multiple endocrine neoplasia type 1

Naruoka Akane1, Sumiko Ohnami1, Takashi Nagashima1,2, Masakuni Serizawa1, Keiichi Hatakeyama1, Keiichi Ohshima1, Shumpei Ohnami1, Yasue Horiuchi1,3, Yoshimi Kiyozumi3, Hiroyuki Matsubayashi3, Kenichi Urakami1, Yasuto Akiyama1, Yamaguchi Ken1,3 (1.Shizuoka Cancer Center Research Institute, Nagaizumi-cho, Japan, 2.SRL Inc., 3.Shizuoka Cancer Center Hospital)

[P3-04-14]Two cases of surveillance using DWIBS in Li-Fraumeni syndrome

Sawaka Yukishige1, Hiroaki Inoue1, Tomohiro Inui1, Soichiro Sasa1, Mariko Misaki1, Masakazu Goto1, Hiroyuki Morino2, Yukiko Yoshida2, Yoko Miyamoto2, Yoshie Imai3, Hiromitsu Takizawa1 (1.Department of Thoracic, Endocrine Surgery and Oncology, Tokushima University Graduate School, Tokushima, Japan, 2.Clinical Genomic Center, Tokushima University Hospital, 3.Tokushima University Graduate School of Biomedical Sciences)

[P3-04-15]Increased Risk of Hepatocarcinogenesis through HBV Integration in Patients with a Good Prognosis and HBx Mutations

Nao Nishida1, Masao Nagasaki2, Masaya Sugiyama3, Takayo Tsuchiura1, Miyuki Ishikawa3, Katsushi Tokunaga4 (1.Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University, 2.Human Biosciences Unit for the Top Global Course Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, 3.Department of Viral Pathogenesis and Controls, National Center for Global Health and Medicine, 4.Genome Medical Science Project-Toyama, National Center for Global Health and Medicine)

[P3-04-16]Cases of patients with tumors harboring BAP1 mutation provided with genetic counseling as secondary findings of CGP

Takumi Fujiwara1,2, Yoshinaga Okugawa1, Tatsuki Tsuruga2, Tomohito Okano2, Takahito Kitajima1, Jyunya Tsuboi1, Ryotaro Hashizume1, Hiroshi Imai1, Makoto Ikejiri1, Ikuyo Mochiki1, Kaname Nakatani1, Tetsu Kobayashi2 (1.Department of Genomic Medicine, Mie University Hospital, Mie, Japan, 2.Department of Pulmonary and Critical Care Medicine, Mie University Faculty and Graduate School of Medicine, Tsu, Japan)

[P3-04-17]Evaluation of Presumed Germline Pathogenic Variants Disclosure in Cancer Gene Panel Testing Conducted at Our Hospital

Mizuki Takatsu1, Junko Kimura1,2, Mitsutoshi Nomura1,2, Masato Nakamura1,2, Hisashi Shimojo1,3, Kyota Oda1,4, Kenji Takagi1,5, Hideaki Moteki1 (1.Department of Medical Genetics, Aizawa Hospital, Nagano, Japan, 2.Aizawa Comprehensive Cancer Center, Aizawa Hospital, Nagano, Japan, 3.Department of Pathology, Aizawa Hospital, Nagano, Japan, 4.Division of Radiation Oncology, Aizawa Hospital, Nagano, Japan, 5.Department of Health Management, Aizawa Health Checkup Center, Nagano, Japan)

[P3-04-18]Evaluation of cancer predisposition gene variants using tumor profiling data

Gou Yamamoto, Katsuya Iuchi, Mikito Kato, Chiharu Okada, Natsuki Naka, Sachiko Kasuya, Tomokazu Wakatsuki, Chie Matsue, Kumi Sakoe, Miho Kakuta, Reiko Yoshida, Kiwamu Akagi (Department of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan)

[P3-04-19]Examination of Genomic Profiling Test for Prostate Cancer at Our Institution

Norihiro Kusumi1, Yuki Kurihara1, Azusa Matsumi1, Moto Tokunaga1, Syogo Watari1, Risa Kubota1, Takaharu Ichikawa1, Tomoyasu Tsushima1, Akira Hirasawa2 (1.Department of Urology, NHO Okayama Medical Center, 2.Department of clinical Genetics and Genomic Medicine, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences)

[P3-04-20]Experience using MGPT for hereditary tumors developed at our hospital and the need for EQA

Kazuyuki Matushita1,2,3, Takayuki Ishige1, Motoi Nishimura1,2,3, Noriko Oonishi2, Tomohiko Ichikawa2,3 (1.Department of Laboratory Medicine, Chiba University Hospital, Japan, 2.Division of Clinical Genetics, Chiba University Hospital, Japan, 3.Center for Cancer Genomes, Chiba University Hospital, Japan)

[P3-04-21]Changes in genetic practice at the designated cancer center over 12 years

Koji Matsumoto1,3, Hiromi Sugawara1, Megumi Mukai1, Sadia Matsutani1, Risa Goto1, Saki Hinosita1,2, Miyuki Kawamura1,3, Hideki Sakai1,3, Mitsunori Morita1,3, Takuma Onoe1,3, Takashi Shibutani1,4, Kyoko Hamasaki1,4, Hirokaga Koichi1,5, Kazuo Tamura1 (1.Division of Clinical Genetics, Hyogo Cancer Center, Akashi, Japan, 2.Division of Nursing, Hyogo Cancer Center, Akashi, Japan, 3.Division of Medical Oncology, Hyogo Cancer Center, Akashi, Japan, 4.Division of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Japan, 5.Division of Breast Surgery, Hyogo Cancer Center, Akashi, Japan)

[P3-04-22]Considerations from our experiences in cancer genomic medicine

Naomi Araki1, Hideyasu Tsumura1,2, Sachiko Ohori1, Rika Kawata1, Masao Araki1, Mina Waraya1, Fumio Takada1,3 (1.Genetics Division, Department of Genetics, Kitasato University Hospital, Kanagawa, Japan, 2.Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan, 3.Department of Medical Genetics and Genomics, Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan)

[P3-04-23]Identification of URST4 as a prognostic factor and therapeutic target for breast cancer

Hoa Thi Nguyen1, Atsushi Takano1,2,3, Yohei Miyagi4, Yataro Daigo1,2,3 (1.Department of Medical Oncology and Cancer Center , Shiga University of Medical Science, 2.Center for Advanced Medicine against Cancer, Shiga University of Medical Science, 3.Center for Antibody and Vaccine Therapy, The University of Tokyo, 4.Molecular Pathology and Genetics Division, Kanagawa Cancer Center)

[P3-04-24]Profiles of T-cell receptor repertoire in long responders to immune checkpoint inhibitors combined with chemotherapy

Jumpei Takeshita1,2, Kazuhiro Yanagihara1 (1.Department of Clinical Oncology, Kansai Electric Power Medical Research Institute, Kyoto, Japan, 2.Department of Medical Oncology, Kitano Hospital)

[P3-04-25]Molecular characterization of ovarian yolk sac tumor in a postmenopausal woman: Implications for pathogenesis

Minoru Nagashima, Mihiro Dejima, Yuka Asami, Yusuke Hirose, Kanae Shimada, Takashi Mimura, Mamiko Onuki, Tetsuya Ishikawa, Akihiko Sekizawa, Koji Matsumoto (Department of Obstetrics and Gynecology, Showa University School of Medicine)

[P3-04-26]Spatial transcriptomics can illuminate the insights into the gene expression profiles of rare prostate cancer subtypes

Ryuta Watanabe1, Haruna Arai1, Noriyoshi Miura1, Mie Kurata2,3, Riko Kitazawa4, Tadahiko Kikugawa1, Takashi Saika1 (1.Ehime University Graduate School of Medicine, 2.Department of Analytical Pathology, Ehime University Graduate School of Medicine, 3.Division of Pathology, Proteo-Science Center, Ehime University, 4.Division of Diagnostic Pathology, Ehime University Hospital)